Harvard Bioscience, Inc. - Enterprise Value

The Enterprise Value as of July 2026 (TTM) for Harvard Bioscience, Inc. (HBIO) is 64.72M

According to Harvard Bioscience, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 64.72M. This represents a change of 10.04% compared to the average of 58.81M of the last 4 quarters.

Harvard Bioscience, Inc. (HBIO) Historical Enterprise Value (quarterly & annually)

How has HBIO Enterprise Value performed in the past?

The mean historical Enterprise Value of Harvard Bioscience, Inc. over the last ten years is 174.35M. The current 64.72M Enterprise Value has changed 3.61% with respect to the historical average. Over the past ten years (40 quarters), HBIO's Enterprise Value was at its highest in in the June 2021 quarter at 380.40M. The Enterprise Value was at its lowest in in the September 2025 quarter at 55.53M.

Harvard Bioscience, Inc. (HBIO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Harvard Bioscience, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Harvard Bioscience, Inc. (HBIO) Average Enterprise Value

How has HBIO Enterprise Value performed in the past?

The current Enterprise Value of Harvard Bioscience, Inc. (HBIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Harvard Bioscience, Inc. (HBIO) Enterprise Value vs. Peers

How is HBIO’s Enterprise Value compared to its peers?

Harvard Bioscience, Inc.’s Enterprise Value is greater than NEXGEL, Inc. (8.86M), greater than Retractable Technologies, Inc. (18.66M), greater than Femasys Inc. (11.39M), greater than Nexalin Technology, Inc. (8.27M), greater than Sonnet BioTherapeutics Holdings, Inc. (3.36M), greater than TAO Synergies Inc. (8.81M), greater than NuCana plc (-14777938.22), greater than Cosmos Health Inc. (35.08M), greater than CollPlant Biotechnologies Ltd. (3.16M),

Build a custom stock screener for Harvard Bioscience, Inc. (HBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Harvard Bioscience, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Harvard Bioscience, Inc. (HBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Harvard Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.